EKNL definitely showed it’s mega strength and as xtremepicks alerted their members at the beginning of the week that investors are in for a MONSTER breakout week and that’s exactly what they got!
Belize City, Belize -- (SBWIRE) -- 10/13/2012 -- Publishers of daily penny stock newsletter xtremepicks (http://www.xtremepicks.com) looks at EKO International (EKNL:PINK)
“EKNL – If you thought last week was insane, you ain’t seen nothing yet“
But this is nothing compared what is lined up for next week including 2 exclusive interviews with the world renowned, Dr. Paul Ziemer and expect MAJOR updates to be unleashed by EKNL
Dr. Ziemer will be interview on Monday with STT Radio
Tune into STT Radio interview Monday at 9am EST at http://www.stocktraderstalk.com/live
Dr. Ziemer will also be featured on Small Cap Voice on Tuesday – watch for additional details soon.
And of course you can follow the play by play on our New Social Media site – DoUKnow.com
Join our exclusive Room and Live CHAT on douknow.com by clicking here
But what really stole the show today was EKNL’s HUGE close at $0.3795 up 26.50% on over 1 million shares traded making a new 52 week high and triggering a bullish breakout that is setting up for a wicked week ahead.
Investors are already seeing the impact of a super low active float of only 5.5 Million shares and no doubt the accumulation since xtremepicks alert at $0.04 put shares in super strong hands. With insiders not selling a single share for less than dollar land, and inventory close to being all dried up, investors are well on our way to xtremepicks target price of $1.25
When xtremepicks MONSTER winner Fuse Science (DROP:OTCBB) reached these level it only took a small catalyst to breakout and hit their price target of $1.25 (83,000%+) dead on. With MEGA news expected to be unleashed by EKNL over the next few day and 2 exclusive interview early next week, no doubt it will be the catalyst to push prices sky high.
Stay tuned for more updates on these exclusive interview.
About EKO International
EKO International Corp. is a holding company focused on growth through acquisition. Each acquisition must have substantial growth potential and is expected to add assets and/or cash-flow to the consolidated financial statements of the Company. The Company is willing to examine a variety of proposed target businesses and if interested, will negotiate terms and conditions of purchase favorable to itself.
About NeuroVasc Clinical Inc
NeuroVasc Clinical Inc. has brought a solution to the North American market place. The patented technology called FREMS is an FDA and Health Canada approved device that uses a patented electrical frequency and duty cycle to stimulate blood vessel re-growth and tissue regeneration in tissue that has compromised nerve and blood vessel function. The patient is treated 10 times once daily for 40 minutes and the effects on the tissue will last up to 18 month depending on the overall health of the patient. Thus this treatment becomes part of the maintenance of the lower limb for the diabetic patient as they age and will be a key player in the prevention of painful neuropathy and the development of dangerous wounds.
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep informed of the latest movers. Xtremepicks.com penny stock newsletter is the trading connection and remember to always do research, use stop loss orders to protect, and book profits when in a position to do so. Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do own due diligence. Xtremepicks did not receive any compensation for the distribution of this press release. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)